{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T21:06:31Z","timestamp":1788123991390,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83767-9","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T14:29:40Z","timestamp":1736778580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders"],"prefix":"10.1038","volume":"15","author":[{"given":"Muhammad Waleed","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakir","family":"ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal A.","family":"Shazly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atrsaw Asrat","family":"Mengistie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"1","key":"83767_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cei.13101","volume":"193","author":"T David","year":"2018","unstructured":"David, T., Ling, S. & Barton, A. Genetics of immune-mediated inflammatory diseases. Clin. Exp. Immunol. 193(1), 3\u201312 (2018).","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"83767_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1124\/pr.114.009639","volume":"67","author":"S Siebert","year":"2015","unstructured":"Siebert, S. et al. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol. Rev. 67(2), 280\u2013309 (2015).","journal-title":"Pharmacol. Rev."},{"key":"83767_CR3","doi-asserted-by":"publisher","first-page":"102374","DOI":"10.1016\/j.jaut.2019.102374","volume":"110","author":"M Aringer","year":"2020","unstructured":"Aringer, M. Inflammatory markers in systemic lupus erythematosus. J. Autoimmun. 110, 102374 (2020).","journal-title":"J. Autoimmun."},{"issue":"2","key":"83767_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. Atherosclerosis\u2014an inflammatory disease. N. Engl. J. Med. 340(2), 115\u2013126 (1999).","journal-title":"N Engl. J. Med."},{"issue":"9573","key":"83767_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart, D. C. & Carding, S. R. Inflammatory bowel disease: cause and immunobiology. Lancet 369(9573), 1627\u20131640 (2007).","journal-title":"Lancet"},{"issue":"7","key":"83767_CR6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"BB Davidovici","year":"2010","unstructured":"Davidovici, B. B. et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J. Investig. Dermatol. 130(7), 1785\u20131796 (2010).","journal-title":"J. Investig. Dermatol."},{"key":"83767_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1590\/S0004-27302010000200007","volume":"54","author":"PGS Lacativa","year":"2010","unstructured":"Lacativa, P. G. S. & Farias, M. L. F. Osteoporosis and inflammation. Arqu. Brasil Endocrinol. Metabol.  54, 123\u2013132 (2010).","journal-title":"Arqu. Brasil Endocrinol. Metabol."},{"issue":"9863","key":"83767_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt, E. & Zillikens, D. Pemphigoid diseases. Lancet 381(9863), 320\u2013332 (2013).","journal-title":"Lancet"},{"issue":"2","key":"83767_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","volume":"27","author":"SE Gabriel","year":"2001","unstructured":"Gabriel, S. E. The epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. N Am. 27(2), 269\u2013281 (2001).","journal-title":"Rheum. Dis. Clin. N Am."},{"key":"83767_CR10","doi-asserted-by":"crossref","unstructured":"Ramos-Casals, M. et al. Sj\u00f6gren\u2019s Syndrome. A Clinician\u2019s Pearls and Myths in Rheumatology 107\u2013130 (Springer, 2009).","DOI":"10.1007\/978-1-84800-934-9_12"},{"issue":"1","key":"83767_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/acr.24988","volume":"75","author":"T Taylor","year":"2023","unstructured":"Taylor, T. et al. Causes of death among individuals with systemic lupus erythematosus by race and ethnicity: a population-based study. Arthritis Care Res. 75(1), 61\u201368 (2023).","journal-title":"Arthritis Care Res."},{"issue":"2","key":"83767_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cjca.2010.12.040","volume":"27","author":"I Roifman","year":"2011","unstructured":"Roifman, I. et al. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can. J. Cardiol. 27(2), 174\u2013182 (2011).","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"83767_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MIB.0b013e3182a827d2","volume":"20","author":"M Dave","year":"2014","unstructured":"Dave, M. et al. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm. Bowel Dis. 201), 196\u2013212 (2014).","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"83767_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02674919","volume":"3","author":"A Parke","year":"1995","unstructured":"Parke, A. & Parke, D. V. The pathogenesis of inflammatory disease: surgical shock and multiple system organ failure. InflammoPharmacology 3(2), 149\u2013168 (1995).","journal-title":"InflammoPharmacology"},{"issue":"3","key":"83767_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3201\/eid0403.980339","volume":"4","author":"GH Cassell","year":"1998","unstructured":"Cassell, G. H. Infectious causes of chronic inflammatory diseases and cancer. Emerg. Infect. Dis. 4(3), 475\u2013487 (1998).","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"83767_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2796.2008.01962.x","volume":"263","author":"CD Packey","year":"2008","unstructured":"Packey, C. D. & Sartor, R. B. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J. Intern. Med. 263(6), 597\u2013606 (2008).","journal-title":"J. Intern. Med."},{"issue":"8","key":"83767_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00109-008-0352-0","volume":"86","author":"NN Singh","year":"2008","unstructured":"Singh, N. N. & Ramji, D. P. Protein kinase CK2, an important regulator of the inflammatory response? J. Mol. Med. 86(8), 887\u2013897 (2008).","journal-title":"J. Mol. Med."},{"key":"83767_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2015.01.003","volume":"94","author":"R Roskoski","year":"2015","unstructured":"Roskoski, R. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacol. Res. 94, 9\u201325 (2015).","journal-title":"Pharmacol. Res."},{"issue":"48","key":"83767_CR19","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1038\/sj.onc.1208081","volume":"23","author":"TJ Boggon","year":"2004","unstructured":"Boggon, T. J. & Eck, M. J. Structure and regulation of src family kinases. Oncogene 23(48), 7918\u20137927 (2004).","journal-title":"Oncogene"},{"issue":"328","key":"83767_CR20","doi-asserted-by":"publisher","first-page":"328ra30","DOI":"10.1126\/scitranslmed.aad7666","volume":"8","author":"E Turro","year":"2016","unstructured":"Turro, E. et al. A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies. Sci. Transl. Med. 8(328), 328ra30 (2016).","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"83767_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0960-9822(00)00024-5","volume":"11","author":"CCK Yu","year":"2001","unstructured":"Yu, C. C. K. et al. Lupus-like kidney disease in mice deficient in the src family tyrosine kinases Lyn and Fyn. Curr. Biol. 11(1), 34\u201338 (2001).","journal-title":"Curr. Biol."},{"issue":"5","key":"83767_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1586\/1744666X.2014.893827","volume":"10","author":"WH Shao","year":"2014","unstructured":"Shao, W. H. & Cohen, P. L. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets. Expert Rev. Clin. Immunol. 10(5), 573\u2013582 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"3","key":"83767_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/ATVBAHA.108.179150","volume":"29","author":"MA Reddy","year":"2009","unstructured":"Reddy, M. A. et al. Role of src tyrosine kinase in the atherogenic effects of the 12\/15-lipoxygenase pathway in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 29(3), 387\u2013393 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"83767_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4292\/wjgpt.v5.i4.209","volume":"5","author":"L Yang","year":"2014","unstructured":"Yang, L. & Yan, Y. Protein kinases are potential targets to treat inflammatory bowel disease. World J. Gastrointest. Pharmacol. Ther. 5(4), 209\u2013217 (2014).","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"83767_CR25","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3389\/fimmu.2019.01862","volume":"10","author":"KP Szilveszter","year":"2019","unstructured":"Szilveszter, K. P., N\u00e9meth, T. & M\u00f3csai, A. Tyrosine kinases in autoimmune and inflammatory skin diseases. Front. Immunol. 10, 1862 (2019).","journal-title":"Front. Immunol."},{"issue":"18","key":"83767_CR26","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1093\/bioinformatics\/btaa565","volume":"36","author":"F Sohraby","year":"2020","unstructured":"Sohraby, F. et al. A boosted unbiased molecular dynamics method for predicting ligands binding mechanisms: probing the binding pathway of dasatinib to src-kinase. Bioinformatics 36(18), 4714\u20134720 (2020).","journal-title":"Bioinformatics"},{"issue":"3","key":"83767_CR27","doi-asserted-by":"publisher","first-page":"103076","DOI":"10.1016\/j.jksus.2023.103076","volume":"36","author":"S Khamouli","year":"2024","unstructured":"Khamouli, S. et al. Comprehensive in silico discovery of c-Src tyrosine kinase inhibitors in cancer treatment: a unified approach combining pharmacophore modeling, 3D QSAR, DFT, and molecular dynamics simulation. J. King Saud Univ. Sci. 36(3), 103076 (2024).","journal-title":"J. King Saud Univ. Sci."},{"key":"83767_CR28","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3389\/fphar.2019.01011","volume":"10","author":"J Rivera-Torres","year":"2019","unstructured":"Rivera-Torres, J., San, E. & Jos\u00e9 Src tyrosine kinase inhibitors: new perspectives on their immune, antiviral, and senotherapeutic potential. Front. Pharmacol. 10, 1011 (2019).","journal-title":"Front. Pharmacol."},{"key":"83767_CR29","doi-asserted-by":"crossref","unstructured":"Sato, H. et al. SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors. JCO Precis Oncol. 6,  e2200088 (2022).","DOI":"10.1200\/PO.22.00088"},{"issue":"5","key":"83767_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1634\/theoncologist.2010-0408","volume":"16","author":"LN Puls","year":"2011","unstructured":"Puls, L. N., Eadens, M. & Messersmith, W. Current status of SRC inhibitors in solid tumor malignancies. Oncologist 16(5), 566\u2013578 (2011).","journal-title":"Oncologist"},{"issue":"2","key":"83767_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/ci500681r","volume":"55","author":"C Scholz","year":"2015","unstructured":"Scholz, C. et al. DOCKTITE a highly versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment. J. Chem. Inf. Model. 55(2), 398\u2013406 (2015).","journal-title":"J. Chem. Inf. Model."},{"issue":"1\u20132","key":"83767_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1504\/IJBRA.2012.045956","volume":"8","author":"MS Mabrouk","year":"2012","unstructured":"Mabrouk, M. S. Discovering best candidates for Hepatocellular Carcinoma (HCC) by in-silico techniques and tools. Int. J. Bioinform Res. Appl. 8(1\u20132), 141\u2013152 (2012).","journal-title":"Int. J. Bioinform Res. Appl."},{"issue":"D1","key":"83767_CR33","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2011","unstructured":"Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40(D1), D1100\u2013D1107 (2011).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"83767_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13321-020-00456-1","volume":"12","author":"AP Bento","year":"2020","unstructured":"Bento, A. P. et al. An open source chemical structure curation pipeline using RDKit. J. Cheminform. 12(1), 51 (2020).","journal-title":"J. Cheminform."},{"issue":"8","key":"83767_CR35","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","volume":"91","author":"WR Proctor","year":"2017","unstructured":"Proctor, W. R. et al. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch. Toxicol. 91(8), 2849\u20132863 (2017).","journal-title":"Arch. Toxicol."},{"key":"83767_CR36","doi-asserted-by":"publisher","first-page":"1380266","DOI":"10.3389\/fchem.2024.1380266","volume":"12","author":"F Siddique","year":"2024","unstructured":"Siddique, F. et al. Revisiting methotrexate and phototrexate Zinc15 library-based derivatives using deep learning in-silico drug design approach. Front. Chem. 12, 1380266 (2024).","journal-title":"Front. Chem."},{"issue":"11","key":"83767_CR37","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/cbdv.200900117","volume":"6","author":"J Wang","year":"2009","unstructured":"Wang, J. & Skolnik, S. Recent advances in physicochemical and ADMET profiling in drug discovery. Chem. Biodivers. 6(11), 1887\u20131899 (2009).","journal-title":"Chem. Biodivers."},{"key":"83767_CR38","doi-asserted-by":"crossref","unstructured":"Bisong, E. Building Machine Learning and deep Learning Models on Google Cloud Platform (Apress, 2019).","DOI":"10.1007\/978-1-4842-4470-8"},{"issue":"7","key":"83767_CR39","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell, J. B. & Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53(7), 2719\u20132740 (2010).","journal-title":"J. Med. Chem."},{"issue":"1","key":"83767_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-019-0351-x","volume":"11","author":"D Sydow","year":"2019","unstructured":"Sydow, D. et al. TeachOpenCADD: a teaching platform for computer-aided drug design using open source packages and data. J. Cheminform.  11(1), 29 (2019).","journal-title":"J. Cheminform."},{"issue":"3","key":"83767_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk, R. et al. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3(3), 435\u2013444 (2008).","journal-title":"ChemMedChem"},{"issue":"7","key":"83767_CR42","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap, C. W. PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J. Comput. Chem. 32(7), 1466\u20131474 (2011).","journal-title":"J. Comput. Chem."},{"issue":"10","key":"83767_CR43","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/sj.mp.4001542","volume":"9","author":"LA Snider","year":"2004","unstructured":"Snider, L. A. & Swedo, S. E. PANDAS: current status and directions for research. Mol. Psychiatry. 9(10), 900\u2013907 (2004).","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"83767_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2174\/18735592MTEzsMDMnz","volume":"22","author":"A Nayarisseri","year":"2021","unstructured":"Nayarisseri, A. et al. Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery. Curr. Drug Targets 22(6), 631\u2013655 (2021).","journal-title":"Curr. Drug Targets"},{"key":"83767_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.eswa.2016.12.008","volume":"72","author":"G Cano","year":"2017","unstructured":"Cano, G. et al. Automatic selection of molecular descriptors using random forest: application to drug discovery. Expert Syst. Appl. 72, 151\u2013159 (2017).","journal-title":"Expert Syst. Appl."},{"key":"83767_CR46","doi-asserted-by":"publisher","first-page":"107269","DOI":"10.1016\/j.compbiolchem.2020.107269","volume":"86","author":"R Arian","year":"2020","unstructured":"Arian, R. et al. Protein kinase inhibitors\u2019 classification using K-Nearest neighbor algorithm. Comput. Biol. Chem. 86, 107269 (2020).","journal-title":"Comput. Biol. Chem."},{"issue":"1","key":"83767_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17460441.2019.1549033","volume":"14","author":"VG Maltarollo","year":"2019","unstructured":"Maltarollo, V. G. et al. Advances with support vector machines for novel drug discovery. Expert Opin. Drug Discov. 14(1), 23\u201333 (2019).","journal-title":"Expert Opin. Drug Discov"},{"issue":"8","key":"83767_CR48","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1021\/acs.jcim.2c00072","volume":"62","author":"PH Bos","year":"2022","unstructured":"Bos, P. H. et al. AutoDesigner, a De Novo Design Algorithm for rapidly exploring large chemical space for lead optimization: application to the design and synthesis of d-Amino acid oxidase inhibitors. J. Chem. Inf. Model. 62(8), 1905\u20131915 (2022).","journal-title":"J. Chem. Inf. Model."},{"key":"83767_CR49","doi-asserted-by":"crossref","unstructured":"Jaskowiak, P. A. et al. A comparative study on the use of correlation coefficients for redundant feature elimination. In 2010 Eleventh Brazilian Symposium on Neural Networks (IEEE, 2010).","DOI":"10.1109\/SBRN.2010.11"},{"issue":"21","key":"83767_CR50","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1021\/acs.jcim.3c01563","volume":"63","author":"A Raza","year":"2023","unstructured":"Raza, A. et al. AIPs-SnTCN: Predicting anti-inflammatory peptides using fasttext and transformer encoder-based hybrid word embedding with self-normalized temporal convolutional networks. J. Chem. Inf. Model. 63(21), 6537\u20136554 (2023).","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"83767_CR51","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","volume":"26","author":"A Altmann","year":"2010","unstructured":"Altmann, A. et al. Permutation importance: a corrected feature importance measure. Bioinformatics 26(10), 1340\u20131347 (2010).","journal-title":"Bioinformatics"},{"issue":"3","key":"83767_CR52","first-page":"183","volume":"4","author":"P Muhamad Iqbal Januadi","year":"2023","unstructured":"Muhamad Iqbal Januadi, P. & Vincent, A. Comparison of machine learning land use-land cover supervised classifiers performance on satellite imagery sentinel 2 using lazy predict library. Indonesian J. Data Sci. 4(3), 183\u2013189 (2023).","journal-title":"Indonesian J. Data Sci."},{"key":"83767_CR53","doi-asserted-by":"publisher","first-page":"115526","DOI":"10.1016\/j.enconman.2022.115526","volume":"258","author":"K Lappalainen","year":"2022","unstructured":"Lappalainen, K., Piliougine, M. & Spagnuolo, G. Experimental comparison between various fitting approaches based on RMSE minimization for photovoltaic module parametric identification. Energy Convers. Manage. 258, 115526 (2022).","journal-title":"Energy Convers. Manage."},{"issue":"2","key":"83767_CR54","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0304-4076(96)01818-0","volume":"77","author":"A Colin Cameron","year":"1997","unstructured":"Colin Cameron, A. & Windmeijer, F. A. G. An R-squared measure of goodness of fit for some common nonlinear regression models. J. Econometr.  77(2), 329\u2013342 (1997).","journal-title":"J. Econometr."},{"key":"83767_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","volume":"443","author":"GM Morris","year":"2008","unstructured":"Morris, G. M. & Lim-Wilby, M. Molecular docking. Methods Mol. Biol. 443, 365\u2013382 (2008).","journal-title":"Methods Mol. Biol."},{"key":"83767_CR56","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","volume":"1607","author":"SK Burley","year":"2017","unstructured":"Burley, S. K. et al. Protein Data Bank (PDB): the single global macromolecular structure archive. Methods Mol. Biol. 1607, 627\u2013641 (2017).","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"83767_CR57","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1080\/07391102.2023.2202247","volume":"42","author":"G Gutti","year":"2024","unstructured":"Gutti, G. et al. In-silico guided design, screening, and molecular dynamic simulation studies for the identification of potential SARS-CoV-2 main protease inhibitors for the targeted treatment of COVID-19. J. Biomol. Struct. Dyn. 42(4), 1733\u20131750 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"83767_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11120-020-00741-y","volume":"144","author":"N Liguori","year":"2020","unstructured":"Liguori, N. et al. Molecular dynamics simulations in photosynthesis. Photosynth Res. 144(2), 273\u2013295 (2020).","journal-title":"Photosynth Res."},{"key":"83767_CR59","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10822-010-9385-x","volume":"24","author":"T Ten Brink","year":"2010","unstructured":"Ten Brink, T. & Exner, T. E. pK a based protonation states and microspecies for protein\u2013ligand docking. J. Comput. Aided Mol. Des. 24, 935\u2013942 (2010).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"4","key":"83767_CR60","doi-asserted-by":"publisher","first-page":"e1003571","DOI":"10.1371\/journal.pcbi.1003571","volume":"10","author":"S Ruiz-Carmona","year":"2014","unstructured":"Ruiz-Carmona, S. et al. rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput. Biol. 10(4), e1003571 (2014).","journal-title":"PLoS Comput. Biol."},{"issue":"6","key":"83767_CR61","doi-asserted-by":"publisher","first-page":"9977","DOI":"10.3390\/molecules20069977","volume":"20","author":"A Cuzzolin","year":"2015","unstructured":"Cuzzolin, A. et al. DockBench: an integrated informatic platform bridging the gap between the robust validation of docking protocols and virtual screening simulations. Molecules 20(6), 9977\u20139993 (2015).","journal-title":"Molecules"},{"key":"83767_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules22010136","volume":"22","author":"A Castro-Alvarez","year":"2017","unstructured":"Castro-Alvarez, A., Costa, A. M. & Vilarrasa, J. The performance of several docking programs at reproducing protein-macrolide-like crystal structures. Molecules 22, 1 (2017).","journal-title":"Molecules"},{"issue":"1","key":"83767_CR63","doi-asserted-by":"publisher","first-page":"e14232","DOI":"10.2196\/14232","volume":"1","author":"SS Butt","year":"2020","unstructured":"Butt, S. S. et al. Molecular docking using chimera and autodock vina software for nonbioinformaticians. JMIR Bioinform. Biotechnol. 1(1), e14232 (2020).","journal-title":"JMIR Bioinform. Biotechnol."},{"issue":"5","key":"83767_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger, D. & de Groot, B. L. Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J. Comput. Aided Mol. Des. 24(5), 417\u2013422 (2010).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"16","key":"83767_CR65","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1080\/10408398.2017.1341864","volume":"58","author":"A Singh","year":"2018","unstructured":"Singh, A. et al. Application of molecular dynamic simulation to study food proteins: a review. Crit. Rev. Food Sci. Nutr. 58(16), 2779\u20132789 (2018).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"13","key":"83767_CR66","doi-asserted-by":"publisher","first-page":"5946","DOI":"10.1080\/07391102.2022.2098823","volume":"41","author":"O Love","year":"2023","unstructured":"Love, O. et al. Evaluating the accuracy of the AMBER protein force fields in modeling dihydrofolate reductase structures: misbalance in the conformational arrangements of the flexible loop domains. J. Biomol. Struct. Dyn. 41(13), 5946\u20135960 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"83767_CR67","unstructured":"Junmei, W. Antechamber, an accessory software packagefor molecular mechanical calculations. J. Chem. Inf. Comput. Sci. (2001)."},{"key":"83767_CR68","doi-asserted-by":"publisher","first-page":"106948","DOI":"10.1016\/j.dib.2021.106948","volume":"35","author":"J Loschwitz","year":"2021","unstructured":"Loschwitz, J. et al. Dataset of AMBER force field parameters of drugs, natural products and steroids for simulations using GROMACS. Data Brief. 35, 106948 (2021).","journal-title":"Data Brief."},{"issue":"3","key":"83767_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/07391102.1991.10507930","volume":"9","author":"RM Kini","year":"1991","unstructured":"Kini, R. M. & Evans, H. J. Molecular modeling of proteins: a strategy for energy minimization by molecular mechanics in the AMBER force field. J. Biomol. Struct. Dyn. 9(3), 475\u2013488 (1991).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"83767_CR70","doi-asserted-by":"publisher","first-page":"024103","DOI":"10.1063\/1.4954990","volume":"145","author":"J Liu","year":"2016","unstructured":"Liu, J., Li, D. & Liu, X. A simple and accurate algorithm for path integral molecular dynamics with the Langevin thermostat. J. Chem. Phys. 145(2), 024103 (2016).","journal-title":"J. Chem. Phys."},{"issue":"12","key":"83767_CR71","doi-asserted-by":"publisher","first-page":"124108","DOI":"10.1063\/1.4978807","volume":"146","author":"Y Lin","year":"2017","unstructured":"Lin, Y. et al. Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation. J. Chem. Phys. 146(12), 124108 (2017).","journal-title":"J. Chem. Phys."},{"issue":"5","key":"83767_CR72","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler, V., van Gunsteren, W. F. & H\u00fcnenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22(5), 501\u2013508 (2001).","journal-title":"J. Comput. Chem."},{"issue":"3","key":"83767_CR73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/00268979000100341","volume":"69","author":"D M\u00f6ller","year":"1990","unstructured":"M\u00f6ller, D. & Fischer, J. Vapour liquid equilibrium of a pure fluid from test particle method in combination with NpT molecular dynamics simulations. Mol. Phys. 69(3), 463\u2013473 (1990).","journal-title":"Mol. Phys."},{"issue":"12","key":"83767_CR74","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.1021\/acs.jctc.2c00586","volume":"18","author":"JA Harris","year":"2022","unstructured":"Harris, J. A. et al. GPU-Accelerated all-atom particle-mesh ewald continuous constant pH molecular dynamics in amber. J. Chem. Theory Comput. 18(12), 7510\u20137527 (2022).","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"83767_CR75","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9(7), 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"83767_CR76","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli, G. et al. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J. Comput. Chem. 31(4), 797\u2013810 (2010).","journal-title":"J. Comput. Chem."},{"issue":"12","key":"83767_CR77","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1021\/jm049081q","volume":"48","author":"B Kuhn","year":"2005","unstructured":"Kuhn, B. et al. Validation and use of the MM-PBSA approach for drug discovery. J. Med. Chem. 48(12), 4040\u20134048 (2005).","journal-title":"J. Med. Chem."},{"issue":"2","key":"83767_CR78","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1021\/acs.jcim.2c01134","volume":"63","author":"R Stoyanova","year":"2023","unstructured":"Stoyanova, R. et al. Computational predictions of nonclinical pharmacokinetics at the drug design stage. J. Chem. Inf. Model. 63(2), 442\u2013458 (2023).","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"83767_CR79","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/C7SC02664A","volume":"9","author":"Z Wu","year":"2018","unstructured":"Wu, Z. et al. MoleculeNet: a benchmark for molecular machine learning. Chem. Sci. 9(2), 513\u2013530 (2018).","journal-title":"Chem. Sci."},{"issue":"3","key":"83767_CR80","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1021\/acs.jcim.8b00550","volume":"59","author":"N Sturm","year":"2019","unstructured":"Sturm, N. et al. Application of bioactivity profile-based fingerprints for building machine learning models. J. Chem. Inf. Model. 59(3), 962\u2013972 (2019).","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"83767_CR81","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/ci8001556","volume":"48","author":"RD Cramer","year":"2008","unstructured":"Cramer, R. D. et al. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA. J. Chem. Inf. Model. 48(11), 2180\u20132195 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"83767_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00210-001-0521-y","volume":"365","author":"P Hannaert","year":"2002","unstructured":"Hannaert, P. et al. Rat NKCC2\/NKCC1 cotransporter selectivity for loop diuretic drugs. Naunyn-Schmiedeberg Arch. Pharmacol. 365, 193\u2013199 (2002).","journal-title":"Naunyn-Schmiedeberg Arch. Pharmacol."},{"key":"83767_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10822-016-9912-5","volume":"30","author":"J Polanski","year":"2016","unstructured":"Polanski, J., Bogocz, J. & Tkocz, A. The analysis of the market success of FDA approvals by probing top 100 bestselling drugs. J. Comput. -Aided Mol. Des. 30, 381\u2013389 (2016).","journal-title":"J. Comput. -Aided Mol. Des."},{"key":"83767_CR84","unstructured":"Masarweh, N. Computational Modelling of Drugs for Alzheimer\u2019s Disease (Ad) and Applications on Artifical Neural Network Systems (Nets) (University of Arkansas at Little Rock, 2021)."},{"key":"83767_CR85","doi-asserted-by":"crossref","unstructured":"Hann, M. M. Molecular obesity, potency and other addictions in drug discovery. In Multifaceted Roles of Crystallography in Modern Drug Discovery 183\u2013196 (Springer, 2015).","DOI":"10.1007\/978-94-017-9719-1_14"},{"key":"83767_CR86","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez, D. & Caballero, J. Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?. Molecules 23, 5 (2018).","DOI":"10.3390\/molecules23051038"},{"issue":"1","key":"83767_CR87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1573409915666190708102459","volume":"16","author":"J Zhu","year":"2020","unstructured":"Zhu, J. et al. Theoretical studies on the selectivity mechanisms of glycogen synthase kinase 3\u03b2 (GSK3\u03b2) with pyrazine ATP-competitive inhibitors by 3D-QSAR, molecular docking, molecular dynamics simulation and free energy calculations. Curr. Comput. -Aided Drug Des. 16(1), 17\u201330 (2020).","journal-title":"Curr. Comput. -Aided Drug Des."},{"issue":"12","key":"83767_CR88","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2165\/00003495-200666120-00012","volume":"66","author":"S Henness","year":"2006","unstructured":"Henness, S. & Perry, C. M. Orlistat: a review of its use in the management of obesity. Drugs 66(12), 1625\u20131656 (2006).","journal-title":"Drugs"},{"issue":"4","key":"83767_CR89","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2165\/00003495-199958040-00015","volume":"58","author":"KM Hvizdos","year":"1999","unstructured":"Hvizdos, K. M. & Markham, A. Orlistat: a review of its use in the management of obesity. Drugs 58(4), 743\u2013760 (1999).","journal-title":"Drugs"},{"issue":"2","key":"83767_CR90","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(02)01422-X","volume":"440","author":"A Ballinger","year":"2002","unstructured":"Ballinger, A. & Peikin, S. R. Orlistat: its current status as an anti-obesity drug. Eur. J. Pharmacol. 440(2), 109\u2013117 (2002).","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"83767_CR91","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2165\/00003495-199346060-00007","volume":"46","author":"JA Balfour","year":"1993","unstructured":"Balfour, J. A. & McTavish, D. Acarbose: an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46(6), 1025\u20131054 (1993).","journal-title":"Drugs"},{"issue":"11","key":"83767_CR92","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/106002809603001110","volume":"30","author":"LK Campbell","year":"1996","unstructured":"Campbell, L. K., White, J. R. & Campbell, R. K. Acarbose: its role in the treatment of diabetes Mellitus. Ann. Pharmacother. 30(11), 1255\u20131262 (1996).","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"83767_CR93","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40262-016-0440-1","volume":"56","author":"S Wind","year":"2017","unstructured":"Wind, S. et al. Clinical pharmacokinetics and pharmacodynamics of afatinib. Clin. Pharmacokinet. 56(3), 235\u2013250 (2017).","journal-title":"Clin. Pharmacokinet."},{"key":"83767_CR94","first-page":"147","volume":"9","author":"T Vaval\u00e0","year":"2017","unstructured":"Vaval\u00e0, T. Role of afatinib in the treatment of advanced lung squamous cell carcinoma. Clin. Pharmacol. 9, 147\u2013157 (2017).","journal-title":"Clin. Pharmacol."},{"issue":"1","key":"83767_CR95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/pr9010071","volume":"9","author":"OM Salo-Ahen","year":"2020","unstructured":"Salo-Ahen, O. M. et al. Molecular dynamics simulations in drug discovery and pharmaceutical development. Processes 9(1), 71 (2020).","journal-title":"Processes"},{"issue":"5","key":"83767_CR96","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","volume":"63","author":"Y Maruyama","year":"2023","unstructured":"Maruyama, Y. et al. Analysis of protein folding simulation with moving root mean square deviation. J. Chem. Inf. Model. 63(5), 1529\u20131541 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"83767_CR97","doi-asserted-by":"crossref","unstructured":"Liu, P. et al. Lubricant shear thinning behavior correlated with variation of radius of gyration via molecular dynamics simulations. J. Chem. Phys. 147, 8 (2017).","DOI":"10.1063\/1.4986552"},{"issue":"2\u20133","key":"83767_CR98","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0301-0104(95)00267-7","volume":"201","author":"A Bizzarri","year":"1995","unstructured":"Bizzarri, A. et al. Hydrogen bond analysis by MD simulation of copper plastocyanin at different hydration levels. Chem. Phys. 201(2\u20133), 463\u2013472 (1995).","journal-title":"Chem. Phys."},{"issue":"1\u20132","key":"83767_CR99","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molliq.2009.01.009","volume":"146","author":"C Chen","year":"2009","unstructured":"Chen, C. et al. Hydrogen bonding analysis of glycerol aqueous solutions: a molecular dynamics simulation study. J. Mol. Liquids 146(1\u20132), 23\u201328 (2009).","journal-title":"J. Mol. Liquids"},{"issue":"9","key":"83767_CR100","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1021\/acs.jcim.8b00478","volume":"58","author":"S Hochreiter","year":"2018","unstructured":"Hochreiter, S., Klambauer, G. & Rarey, M. Machine learning in drug discovery. J. Chem. Inf. Model. 58(9), 1723\u20131724 (2018).","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"83767_CR101","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cbdd.14057","volume":"100","author":"S Priya","year":"2022","unstructured":"Priya, S. et al. Machine learning approaches and their applications in drug discovery and design. Chem. Biol. Drug Des. 100(1), 136\u2013153 (2022).","journal-title":"Chem. Biol. Drug Des."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83767-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:10:29Z","timestamp":1736781029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83767-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83767"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83767-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1836"}}